Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription 18.03.2019 8 Ann Surg Oncol 3 Anticancer Res 5 BMC Cancer 1 Br J Cancer 2 Cancer 1 Cancer Lett 3 Cancer Res 13 Dis Colon Rectum 1 Eur J Cancer 1 Eur J Surg Oncol 6 Int J Cancer 2 Int J Oncol 1 J Clin Oncol 1 J Nucl Med 2 J Surg Oncol 2 Lancet Gastroenterol Hepatol 1 Lancet Oncol 2 Oncol Rep 1 PLoS One 1 Proc Natl Acad Sci U S A 1 World J Surg

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Surg Oncol

1. ARSONIADIS EG, Fan Y, Jarosek S, Gaertner WB, et al
   Decreased Use of Sphincter-Preserving Procedures Among African Americans with Rectal Cancer.
   Ann Surg Oncol. 2018;25:720-728.
   PubMed     Text format     Abstract available
   
   
2. BLOK RD, Musters GD, Borstlap WAA, Buskens CJ, et al
   Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer.
   Ann Surg Oncol. 2018;25:729-736.
   PubMed     Text format     Abstract available
   
   
3. DHIR M, Zenati MS, Jones HL, Bartlett DL, et al
   Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).
   Ann Surg Oncol. 2018;25:550-557.
   PubMed     Text format     Abstract available
   
   
4. ZHOU H, Ruan C, Wang Z, Hu Z, et al
   Laparoscopic-Assisted Modified Intersphincter Resection for Ultralow Rectal Cancer.
   Ann Surg Oncol. 2018;25:947-948.
   PubMed     Text format     Abstract available
   
   
5. PARK JS, Ng KS, Saw RPM, Thompson JF, et al
   Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience.
   Ann Surg Oncol. 2018 Apr 24. pii: 10.1245/s10434-018-6451.
   PubMed     Text format     Abstract available
   
   
6. KIM WR, Han YD, Min BS
   C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy.
   Ann Surg Oncol. 2018;25:3898-3905.
   PubMed     Text format     Abstract available
   
   
7. CHOUDRY MHA, Shuai Y, Jones HL, Pai RK, et al
   Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies.
   Ann Surg Oncol. 2018;25:3950-3959.
   PubMed     Text format     Abstract available
   
   
8. STEWART CL, Gleisner A, Halpern A, Ibrahim-Zada I, et al
   Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia.
   Ann Surg Oncol. 2018;25:655-659.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

9. LI CC, Liang JA, Chung CY, Chen WT, et al
   Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis.
   Anticancer Res. 2019;39:1479-1484.
   PubMed     Text format     Abstract available
   
   
10. HANSEN HC, Janssen S, Thieme C, Perlov A, et al
    Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.
    Anticancer Res. 2019;39:1343-1346.
    PubMed     Text format     Abstract available
    
    
11. REZNICZEK GA, Grunwald C, Hilal Z, Scheich J, et al
    ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).
    Anticancer Res. 2019;39:1267-1273.
    PubMed     Text format     Abstract available
    
    

    
    BMC Cancer

12. POMPSCH M, Vogel J, Classen F, Kranz P, et al
    The presumed MTH1-inhibitor TH588 sensitizes colorectal carcinoma cells to ionizing radiation in hypoxia.
    BMC Cancer. 2018;18:1190.
    PubMed     Text format     Abstract available
    
    
13. VAN BLARIGAN EL, Chan H, Van Loon K, Kenfield SA, et al
    Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial.
    BMC Cancer. 2019;19:218.
    PubMed     Text format     Abstract available
    
    
14. CHEN Y, Tan F, Wei L, Li X, et al
    Sleep duration and the risk of cancer: a systematic review and meta-analysis including dose-response relationship.
    BMC Cancer. 2018;18:1149.
    PubMed     Text format     Abstract available
    
    
15. YAMAURA M, Yamada T, Watanabe R, Kawai H, et al
    Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report.
    BMC Cancer. 2018;18:1142.
    PubMed     Text format     Abstract available
    
    
16. HU H, Huang J, Lan P, Wang L, et al
    CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial.
    BMC Cancer. 2018;18:1145.
    PubMed     Text format     Abstract available
    
    

    
    Br J Cancer

17. IJSSELSTEIJN ME, Petitprez F, Lacroix L, Ruano D, et al
    Revisiting immune escape in colorectal cancer in the era of immunotherapy.
    Br J Cancer. 2019 Mar 13. pii: 10.1038/s41416-019-0421.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

18. ESPLEN MJ, Harrington S, Leung YW, Aronson M, et al
    Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: A randomized controlled trial.
    Cancer. 2019 Mar 12. doi: 10.1002/cncr.32032.
    PubMed     Text format     Abstract available
    
    
19. WILLAUER AN, Liu Y, Pereira AAL, Lam M, et al
    Clinical and molecular characterization of early-onset colorectal cancer.
    Cancer. 2019 Mar 11. doi: 10.1002/cncr.31994.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

20. YANG J, Xu WW, Hong P, Ye F, et al
    Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction.
    Cancer Lett. 2019 Mar 11. pii: S0304-3835(19)30149.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

21. WEISNER J, Landel I, Reintjes C, Uhlenbrock N, et al
    Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer.
    Cancer Res. 2019 Mar 11. pii: 0008-5472.CAN-18-2861.
    PubMed     Text format     Abstract available
    
    
22. VALERI N
    Streamlining Detection of Fusion Genes in Colorectal Cancer: Having "Faith" in Precision Oncology in the (Tissue) "Agnostic" Era.
    Cancer Res. 2019;79:1041-1043.
    PubMed     Text format     Abstract available
    
    
23. KATONA BW, Glynn RA, Paulosky KE, Feng Z, et al
    Combined menin and EGFR inhibitors synergize to suppress colorectal cancer via EGFR-independent and calcium-mediated repression of SKP2 transcription.
    Cancer Res. 2019 Mar 15. pii: 0008-5472.CAN-18-2133.
    PubMed     Text format     Abstract available
    
    

    
    Dis Colon Rectum

24. MELNITCHOUK N, Saadat LV, Bleday R, Goldberg JE, et al
    A Decision Analysis for Rectal-Sparing Familial Adenomatous Polyposis: Total Colectomy With Ileorectal Anastomosis Versus Proctocolectomy With IPAA.
    Dis Colon Rectum. 2019;62:27-32.
    PubMed     Text format     Abstract available
    
    
25. PIENIOWSKI EHA, Palmer GJ, Juul T, Lagergren P, et al
    Low Anterior Resection Syndrome and Quality of Life After Sphincter-Sparing Rectal Cancer Surgery: A Long-term Longitudinal Follow-up.
    Dis Colon Rectum. 2019;62:14-20.
    PubMed     Text format     Abstract available
    
    
26. GONCALVES JCN, Macedo ACL, Madeira K, Bavaresco DV, et al
    Accuracy of Anal Cytology for Diagnostic of Precursor Lesions of Anal Cancer: Systematic Review and Meta-analysis.
    Dis Colon Rectum. 2019;62:112-120.
    PubMed     Text format     Abstract available
    
    
27. YAMAMOTO A, Toiyama Y, Okugawa Y, Oki S, et al
    Clinical Implications of Pretreatment: Lymphocyte-to-Monocyte Ratio in Patients With Rectal Cancer Receiving Preoperative Chemoradiotherapy.
    Dis Colon Rectum. 2019;62:171-180.
    PubMed     Text format     Abstract available
    
    
28. KARAGKOUNIS G, Liska D, Kalady MF
    Conditional Probability of Survival After Neoadjuvant Chemoradiation and Proctectomy for Rectal Cancer: What Matters and When.
    Dis Colon Rectum. 2019;62:33-39.
    PubMed     Text format     Abstract available
    
    
29. AKER M, Ganeshan B, Afaq A, Wan S, et al
    Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
    Dis Colon Rectum. 2018 Nov 15. doi: 10.1097/DCR.0000000000001224.
    PubMed     Text format     Abstract available
    
    
30. KWAK JM, Romagnolo L, Wijsmuller A, Gonzalez C, et al
    Stereotactic Pelvic Navigation With Augmented Reality for Transanal Total Mesorectal Excision.
    Dis Colon Rectum. 2019;62:123-129.
    PubMed     Text format     Abstract available
    
    
31. FERNANDEZ LM, Parlade A, Wasser E, Dasilva G, et al
    How Reliable Is CT Scan in Staging Right Colon Cancer?
    Dis Colon Rectum. 2019 Mar 8. doi: 10.1097/DCR.0000000000001387.
    PubMed     Text format     Abstract available
    
    
32. HUBER T, Hadzijusufovic E, Hansen C, Paschold M, et al
    Head-Mounted Mixed-Reality Technology During Robotic-Assisted Transanal Total Mesorectal Excision.
    Dis Colon Rectum. 2019;62:258-261.
    PubMed     Text format     Abstract available
    
    
33. QUEZADA-DIAZ F, Jimenez-Rodriguez RM, Rawdon K, Garcia-Aguilar J, et al
    Fully Robotic Resection of a Splenic Flexure Tumor with Intracorporeal Anastomosis.
    Dis Colon Rectum. 2019;62:257.
    PubMed     Text format    
    
    
34. YU H, Hemminki A, Sundquist K, Hemminki K, et al
    Familial Associations of Colon and Rectal Cancers With Other Cancers.
    Dis Colon Rectum. 2019;62:189-195.
    PubMed     Text format     Abstract available
    
    
35. SKANCKE M, Arnott SM, Amdur RL, Siegel RS, et al
    Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
    Dis Colon Rectum. 2019;62:181-188.
    PubMed     Text format     Abstract available
    
    
36. OKORJI LM, Kasten KR
    Diagnosis and Management of Parastomal Hernias.
    Dis Colon Rectum. 2019;62:158-162.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

37. PUCCINI A, Loupakis F, Stintzing S, Cao S, et al
    Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3.
    Eur J Cancer. 2019;111:138-147.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

38. MCSORLEY ST, Tham A, Steele CW, Dolan RD, et al
    Quantitative data on red cell measures of iron status and their relation to the magnitude of the systemic inflammatory response and survival in patients with colorectal cancer.
    Eur J Surg Oncol. 2019 Feb 27. pii: S0748-7983(19)30300.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

39. HAMERS FF, Assogba FAG, Rogel A
    Implementation and organization of cancer screening in France.
    Int J Cancer. 2018;143:3281.
    PubMed     Text format    
    
    
40. TOKUNAGA R, Cao S, Naseem M, Battaglin F, et al
    AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: a meta-analysis using TRIBE, MAVERICC, and FIRE3.
    Int J Cancer. 2019 Mar 11. doi: 10.1002/ijc.32261.
    PubMed     Text format     Abstract available
    
    
41. XIN J, Du M, Gu D, Ge Y, et al
    Combinations of Single Nucleotide Polymorphisms Identified in Genome-wide Association Studies Determine Risk for Colorectal Cancer.
    Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32267.
    PubMed     Text format     Abstract available
    
    
42. EL KINANY K, Huybrechts I, Kampman E, Boudouaya HA, et al
    Concordance with the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention and colorectal cancer risk in Morocco: A large, population-based case-control study.
    Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32263.
    PubMed     Text format     Abstract available
    
    
43. BALAVARCA Y, Weigl K, Thomsen H, Brenner H, et al
    Performance of individual and joint risk stratification by an environmental risk score and a genetic risk score in a colorectal cancer screening setting.
    Int J Cancer. 2019 Mar 14. doi: 10.1002/ijc.32272.
    PubMed     Text format     Abstract available
    
    
44. SUGIYAMA H, Misumi M, Brenner A, Grant EJ, et al
    Radiation risk of incident colorectal cancer by anatomical site among atomic bomb survivors: 1958-2009.
    Int J Cancer. 2019 Mar 15. doi: 10.1002/ijc.32275.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

45. PARK YL, Ha SY, Park SY, Choi JH, et al
    Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells.
    Int J Oncol. 2019 Mar 13. doi: 10.3892/ijo.2019.4746.
    PubMed     Text format     Abstract available
    
    
46. KIM SL, Min IS, Park YR, Lee ST, et al
    [Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPKmediated DR5 regulation in colorectal cancer.
    Int J Oncol. 2019 Mar 13. doi: 10.3892/ijo.2019.4748.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

47. INNOCENTI F, Ou FS, Qu X, Zemla TJ, et al
    Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome.
    J Clin Oncol. 2019 Mar 13:JCO1801798. doi: 10.1200/JCO.18.01798.
    PubMed     Text format     Abstract available
    
    

    
    J Nucl Med

48. WOFF E, Kehagias P, Vandeputte C, Ameye L, et al
    Combining (18)F-FDG PET/CT-based Metabolically Active Tumor Volume and Circulating Cell-free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.222919. doi: 10.2967/jnumed.118.222919.
    PubMed     Text format     Abstract available
    
    

    
    J Surg Oncol

49. ADVANI S, Kopetz S
    Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials.
    J Surg Oncol. 2019 Mar 10. doi: 10.1002/jso.25441.
    PubMed     Text format     Abstract available
    
    
50. ENG OS, Turaga KK
    Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer.
    J Surg Oncol. 2019 Mar 10. doi: 10.1002/jso.25438.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

51. TAIEB J
    How best to treat older patients with metastatic colorectal cancer?
    Lancet Gastroenterol Hepatol. 2019 Mar 6. pii: S2468-1253(19)30076.
    PubMed     Text format    
    
    
52. WINTHER SB, Liposits G, Skuladottir H, Hofsli E, et al
    Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial.
    Lancet Gastroenterol Hepatol. 2019 Mar 6. pii: S2468-1253(19)30041.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

53. MERIC-BERNSTAM F, Hurwitz H, Raghav KPS, McWilliams RR, et al
    Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
    Lancet Oncol. 2019 Mar 8. pii: S1470-2045(18)30904.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

54. NAGASU S, Sudo T, Kinugasa T, Yomoda T, et al
    Yboxbinding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7038.
    PubMed     Text format     Abstract available
    
    
55. ZHANG T, Liu L, Lai W, Zeng Y, et al
    Interaction with tumorassociated macrophages promotes PRL3induced invasion of colorectal cancer cells via MAPK pathwayinduced EMT and NFkappaB signalinginduced angiogenesis.
    Oncol Rep. 2019 Mar 7. doi: 10.3892/or.2019.7049.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

56. ACKERMANN A, Schrecker C, Bon D, Friedrichs N, et al
    Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer.
    PLoS One. 2019;14:e0213411.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

57. VAN DER HEIJDEN M, Miedema DM, Waclaw B, Veenstra VL, et al
    Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts.
    Proc Natl Acad Sci U S A. 2019 Mar 8. pii: 1813417116.
    PubMed     Text format     Abstract available
    
    

    
    World J Surg

58. MAZZOTTI F, Cucchetti A, Claassen YHM, Bos ACRK, et al
    Years of Life Lost for Older Patients After Colorectal Cancer Diagnosis.
    World J Surg. 2019 Mar 12. pii: 10.1007/s00268-019-04978.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: